av/onxeo-sa--big.svg

COM:VALERIOTX

Valerio Therapeutics

  • Stock

EUR

Last Close

0.08

25/11 08:24

Market Cap

15.49M

Beta: -

Volume Today

7.30K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
2.94K
-
34.16K
1,061.05%
85.59K
150.56%
145K
69.42%
107K
26.21%
38.50K
64.02%
55.50K
44.16%
32K
42.34%
372K
-
average payables
4.17M
-
5.62M
34.55%
6.52M
16.07%
7.80M
19.71%
7.60M
2.60%
5.05M
33.55%
3.91M
22.61%
3.22M
17.69%
2.80M
13.06%
3.14M
12.28%
2.95M
5.95%
average receivables
2.56M
-
2.56M
0%
3.90M
52.57%
7.62M
95.41%
3.72M
51.17%
2.76M
-
2.76M
0%
1.68M
-
book value per share
0.36
-
2.99
736.57%
2.52
15.72%
1.99
21.12%
0.98
50.81%
0.85
13.36%
0.24
71.50%
0.40
65.53%
0.37
6.53%
0.11
-
capex per share
-0.00
-
-0.00
97.80%
-0.01
12,552.44%
-0.01
88.64%
-0.00
88.93%
-0.00
34.11%
-0.00
56.52%
-0.00
348.71%
-0.00
3.76%
0.00
-
capex to depreciation
-13.37
-
-0.00
99.98%
-0.11
4,727.61%
-0.34
200.78%
-0.00
99.52%
-0.00
203.73%
-0.00
79.12%
0.01
1,514.81%
-0.27
1,977.82%
2.92
1,174.26%
0.36
87.65%
capex to operating cash flow
0.00
-
0.00
92.14%
0.01
4,127.11%
0.03
187.33%
0.00
92.57%
0.00
73.79%
0.00
15.45%
0.03
653.26%
0.02
36.26%
0.05
218.70%
-0.01
119.04%
capex to revenue
-0.03
-
-0.00
99.71%
-0.07
80,133.27%
-0.12
72.27%
-0.01
94.45%
-0.01
7.40%
-0.01
17.44%
-0.07
1,005.06%
-0.03
48.93%
-0.34
888.28%
0.10
130.06%
cash per share
0.54
-
1.40
157.69%
0.83
40.95%
0.62
25.42%
0.28
54.70%
0.21
24.98%
0.08
61.83%
0.20
149.44%
0.20
1.47%
0.05
-
days of inventory on hand
4.34
-
95.59
2,100.65%
114.81
20.10%
102.53
10.69%
17.27
83.16%
79.79
361.98%
66.74
16.35%
days payables outstanding
6.29K
-
9.79K
55.58%
6.89K
29.63%
5.15K
25.23%
3.43K
33.45%
7.04K
105.22%
3.83K
45.58%
519.12
86.44%
2.81K
441.09%
2.45K
12.81%
1.68K
31.27%
days sales outstanding
1.27K
-
817.42
-
613.83
24.91%
469.10
-
383.05
-
debt to assets
0.01
-
0.01
179.71%
0.01
57.58%
0.01
2.59%
0.01
46.65%
0.11
1,178.47%
0.22
97.63%
0.13
38.86%
0.28
106.80%
0.23
15.85%
0.24
1.14%
debt to equity
0.01
-
0.02
46.11%
0.01
57.21%
0.01
3.02%
0.01
72.66%
0.16
1,037.75%
0.48
210.42%
0.22
55.25%
0.45
107.98%
0.45
1.07%
0.56
24.55%
dividend yield
0.22
-
0.08
63.35%
earnings yield
-2.73
-
-0.70
74.37%
-1.76
152.11%
-1.77
0.67%
-4.29
141.79%
-0.65
84.86%
-1.75
170.04%
0.06
103.17%
-0.25
549.17%
-0.91
-
enterprise value
-5.62M
-
-44.58M
693.66%
-17.40M
60.97%
-11.05M
36.49%
-369.23K
96.66%
10.27M
2,880.41%
21.81M
112.45%
11.36M
47.93%
20.69M
82.22%
-4.50M
121.74%
24.56M
645.98%
enterprise value over ebitda
0.38
-
-12.94
3,508.67%
0.96
107.39%
0.56
41.66%
0.01
97.40%
-10.84
74,956.68%
2.96
127.28%
-1.39
146.94%
-4.23
204.41%
0.26
106.23%
-1.33
605.70%
ev to operating cash flow
0.40
-
5.77
1,348.18%
0.75
86.96%
0.63
16.63%
0.01
97.92%
-0.91
7,079.65%
-2.83
210.88%
-2.43
14.31%
-2.41
0.56%
0.48
119.73%
-1.32
377.23%
ev to sales
-3.83
-
-2.02
47.28%
-5.00
147.49%
-2.50
50.01%
-0.04
98.44%
1.68
4,413.33%
5.09
203.56%
6.39
25.72%
5.09
20.33%
-3.12
161.19%
13.64
537.70%
free cash flow per share
-0.68
-
-0.19
72.13%
-0.57
202.46%
-0.38
33.04%
-0.56
44.89%
-0.21
62.02%
-0.11
48.61%
-0.07
39.12%
-0.10
49.61%
-0.14
-
free cash flow yield
-2.52
-
-0.70
72.13%
-2.12
202.46%
-1.42
33.04%
-2.06
44.89%
-0.78
62.02%
-0.40
48.61%
-0.24
39.12%
-0.37
49.61%
-0.84
-
graham net net
0.23
-
0.67
185.94%
0.32
51.32%
0.08
74.62%
-0.27
430.56%
-0.12
55.03%
-0.15
20.91%
-0.04
72.64%
-0.03
37.54%
-0.09
-
graham number
2.43
-
3.56
46.44%
5.19
45.77%
4.63
10.89%
5.05
9.06%
1.83
63.78%
1.60
12.27%
0.37
77.11%
0.75
104.90%
0.61
-
income quality
0.92
-
1.00
9.06%
1.19
18.72%
0.78
34.78%
0.48
38.36%
1.20
150.36%
0.23
80.96%
-4.30
1,981.87%
1.44
133.61%
0.48
66.57%
0.91
89.37%
intangibles to total assets
0.00
-
0.58
44,949.45%
0.67
15.52%
0.70
4.32%
0.61
12.66%
0.61
0.16%
0.62
1.79%
0.44
28.87%
0.39
12.37%
0.48
24.36%
0.58
20.97%
interest coverage
-53.74
-
-0.19
99.64%
-18.40
9,347.20%
-53.02
188.08%
-17.16
67.63%
-15.09
12.11%
-9.44
37.39%
-8.15
13.73%
-3.29
59.61%
-7.82
137.56%
-307.39
3,831.55%
interest debt per share
0.02
-
0.13
620.82%
0.05
62.73%
0.02
48.97%
0.04
41.40%
0.15
327.71%
0.13
13.22%
0.10
24.08%
0.19
87.93%
0.06
-
inventory turnover
84.03
-
3.82
95.46%
3.18
16.74%
3.56
11.97%
21.13
493.67%
4.57
78.35%
5.47
19.55%
invested capital
0.01
-
0.02
46.11%
0.01
57.21%
0.01
3.02%
0.01
72.66%
0.16
1,037.75%
0.48
210.42%
0.22
55.25%
0.45
107.98%
0.45
1.07%
23.93M
5,281,619,150.59%
market cap
5.62M
-
11.02M
96.03%
11.02M
0%
12.79M
16.03%
13.78M
7.76%
14.48M
5.07%
19.24M
32.89%
19.62M
2.00%
23.82M
21.38%
22.38M
-
net current asset value
6.14M
-
32.92M
436.34%
15.26M
53.65%
5.86M
61.62%
2.66M
54.62%
2.53M
4.89%
-9.15M
461.87%
5.71M
162.39%
10.01M
75.43%
-237K
102.37%
-7.47M
3,053.59%
net debt to ebitda
0.76
-
-16.13
2,224.79%
1.56
109.68%
1.20
22.96%
0.55
53.89%
4.45
701.20%
0.35
92.15%
1.01
189.64%
0.64
36.88%
0.26
58.72%
-0.12
144.89%
net income per share
-0.74
-
-0.19
74.37%
-0.48
152.11%
-0.48
0.67%
-1.16
141.79%
-0.18
84.86%
-0.47
170.04%
0.01
103.17%
-0.07
549.17%
-0.15
-
operating cash flow per share
-0.68
-
-0.19
72.04%
-0.57
199.32%
-0.37
34.35%
-0.55
49.03%
-0.21
62.09%
-0.11
48.57%
-0.06
40.43%
-0.10
50.97%
-0.14
-
payables turnover
0.06
-
0.04
35.72%
0.05
42.11%
0.07
33.74%
0.11
50.26%
0.05
51.27%
0.10
83.76%
0.70
637.67%
0.13
81.52%
0.15
14.69%
0.22
45.50%
receivables turnover
0.29
-
0.45
-
0.59
33.17%
0.78
-
0.95
-
research and ddevelopement to revenue
0.44
-
3.64
736.21%
3.18
12.66%
1.62
49.17%
0.80
50.26%
1.36
69.40%
1.19
12.89%
0.75
36.63%
5.46
625.68%
5.38
1.44%
return on tangible assets
-0.86
-
-0.12
86.10%
-0.45
276.79%
-0.60
32.16%
-1.93
223.26%
-0.38
80.31%
-2.36
520.51%
0.04
101.77%
-0.18
535.25%
-0.88
379.49%
-1.38
57.69%
revenue per share
0.07
-
0.54
667.98%
0.09
84.23%
0.09
9.50%
0.19
99.37%
0.11
38.65%
0.06
47.34%
0.02
59.40%
0.05
88.44%
0.01
-
roe
-2.06
-
-0.06
96.94%
-0.19
199.13%
-0.24
27.62%
-1.18
391.55%
-0.21
82.52%
-1.96
847.40%
0.04
101.91%
-0.18
580.54%
-0.88
387.39%
-1.37
56.44%
roic
-2.14
-
-0.01
99.68%
-0.19
2,673.43%
-0.25
31.23%
-0.34
33.83%
-0.25
25.07%
-0.33
30.60%
-0.12
62.57%
-0.11
6.99%
-0.52
356.11%
-0.88
68.31%
sales general and administrative to revenue
7.30
-
0.93
-
0.69
25.93%
1.36
97.03%
0.58
57.72%
1.83
217.26%
1.45
20.56%
shareholders equity per share
0.36
-
2.99
736.57%
2.52
15.72%
1.99
21.12%
0.98
50.81%
0.85
13.36%
0.24
71.50%
0.40
65.53%
0.37
6.53%
0.11
-
stock based compensation to revenue
0.20
-
0.03
83.05%
0.11
218.83%
0.11
1.46%
0.10
5.37%
0.15
46.74%
0.10
32.02%
0.04
56.75%
0.06
23.97%
0.50
809.84%
0.29
43.09%
tangible asset value
7.41M
-
34.04M
359.06%
16.43M
51.73%
6.88M
58.15%
2.34M
65.98%
6.83M
191.96%
-6.16M
190.22%
8.50M
238.00%
12.41M
45.98%
1.54M
87.60%
-5.73M
472.06%
tangible book value per share
0.36
-
0.83
134.18%
0.40
51.73%
0.15
63.93%
0.05
68.43%
0.13
177.88%
-0.09
167.89%
0.12
235.29%
0.14
20.27%
-0.04
-
working capital
9.62M
-
50.03M
419.78%
31.09M
37.85%
24.45M
21.35%
12.02M
50.86%
11.98M
0.27%
5.08M
57.56%
17.13M
236.87%
23.07M
34.68%
13.43M
41.79%
1.86M
86.11%

All numbers in EUR (except ratios and percentages)